Kaletra

Product NDC
21695-362
11-digit product format
216950362
Labeler code
21695
Product ID
21695-362_20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
lopinavir and ritonavir
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Rebel Distributors Corp
Application
NDA021906
Marketing category
NDA
Marketing start
2010-06-18
Marketing end
0000-00-00
Substance
LOPINAVIR; RITONAVIR
Active strength
200 mg/1; mg/1
Pharmacologic classes
HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1d2364f5-8b1e-7c9a-4518-7b359d95fa50Product name220250116
00d976a9-a12a-db3d-ac4e-27498af714cfProduct name520250115
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
7a5f5ac7-15c0-4d8b-bea4-b3b28cb83a8dProduct name120231023
c8f34825-48cd-e7db-4048-c3be840a9308Product name520230123
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d1ee4fdb-1116-417b-8889-dc05571445b3Product name120160825
f8d26468-b1dc-49d8-a188-8b5d531405efProduct name120150731
0b1bb9d1-e628-4e7c-aada-fd6532257932Product name120150416
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
96979b26-bb9a-43d8-e3a6-d69b9e9f75e5Product name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
21695-362-12Kaletra12 in 1 BOTTLETABLET, FILM COATED121

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
21695-362-12EA - Each21695-3620ce04b7f-f139-4c8a-aa1b-acd9c77d0f6612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LOPINAVIRACTIVE INGREDIENT2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
RITONAVIRACTIVE INGREDIENTO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
LOPINAVIRACTIVE MOIETY2494G1JF75KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
RITONAVIRACTIVE MOIETYO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
SORBITAN MONOLAURATEINACTIVE INGREDIENT6W9PS8B71JKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
TALCINACTIVE INGREDIENT7SEV7J4R1UKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
21695-362KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]1Legacy NDC, 1 package rows20110104_20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
847741Kaletra 200 MG / 50 MG Oral TabletPSN20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c1
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletPSN20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c1
847741lopinavir 200 MG / ritonavir 50 MG Oral Tablet [Kaletra]SBD20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c1
597730lopinavir 200 MG / ritonavir 50 MG Oral TabletSCD20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c1
847741Kaletra 200 MG / 50 MG Oral TabletSY20f8c35b-bf1c-44cf-bdd7-01b56b85bc0c1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
21695-362-122169503621212 in 1 BOTTLEHistorical